Drug intelligence / Profile preview

Immunofree

Development stage
Unknown
Lead developer
Biogetica
Modality
Small Molecules
Administration
Oral
01

Overview

Immunofree is a polyherbal Ayurvedic proprietary medicine developed as an antiviral and immunomodulatory therapy, primarily investigated for the treatment of mild to moderate COVID-19. The formulation contains 15 specific herbal extracts, including Kalmegh (*Andrographis paniculata*), Bhumyamalaki (*Phyllanthus niruri*), Licorice (*Glycyrrhiza glabra*), and Artemisia (*Damanaka*), which are traditionally used for respiratory health and immune support. The drug is designed to reduce viral load and manage symptoms by inhibiting viral replication and modulating the body's inflammatory response. It was evaluated in clinical trials (such as NCT04494204) in combination with Reginmune, demonstrating potential in speeding up recovery and clearing viral infections.

Brand names
Immunofree
Other names
Immunofree TabletImmunofree Tablets
02

Targets

Neuraminidase

Beyond the preview

Go deeper on Immunofree.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunofree.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call